Related Experiment Video
Updated: May 21, 2025

09:31
Gold Nanorod-assisted Optical Stimulation of Neuronal Cells
Published on: April 27, 2015
8.9K
Intravitreally Injected Plasmonic Nanorods Activate Bipolar Cells with Patterned Near-Infrared Laser Projection.
Jiarui Nie1,2,3, Kyungsik Eom1,4, Hafithe M AlGhosain1,3
1School of Engineering, Brown University, Providence Rhode Island 02912, United States.
ACS Nano
|March 20, 2025
Summary
Researchers developed a less invasive retinal prosthesis using gold nanorods (AuNRs) for vision restoration. This method precisely activates retinal cells with near-infrared light, offering improved spatial resolution for treating blindness.
Area of Science:
- Biomedical Engineering
- Neuroscience
- Ophthalmology
Background:
- Degenerative retinal diseases cause vision loss, necessitating prosthetic solutions.
- Current retinal prostheses have limitations like invasiveness, limited resolution, and interference with residual vision.
- Nanoparticle-based methods offer minimally invasive options but may use visible light.
Purpose of the Study:
- To develop a less invasive retinal prosthesis using gold nanorods (AuNRs) for vision restoration.
- To achieve precise neural activation via patterned near-infrared (NIR) light stimulation.
- To target bipolar cells for high-resolution visual restoration.
Main Methods:
- Intravitreal injection of anti-Thy1 antibody-conjugated AuNRs.
- Patterned NIR laser scanning (20 μm spot size) for photothermal stimulation.
- In vivo electrocorticogram (ECoG) recordings in wild-type and blind mice.
Main Results:
- Localized neuronal activation of bipolar cells via photothermal effect.
- Evoked ECoG responses in the visual cortex of both mouse models.
- No significant systemic toxicity or retinal damage observed.
Conclusions:
- This approach offers a precise, customizable, and less invasive method for vision restoration.
- The technique demonstrates potential for significant advancements in spatial resolution and broad applicability.
- Patterned NIR stimulation with AuNRs shows promise for treating blindness caused by retinal degeneration.

